Purchases and Sales Made in Q4 2024 in Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX) during Q4 2024. The information is specifically focused on institutions that hold shares of Protalix BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
679K+ 1299.37% |
$673K - $1.3M
|
732K
$1.7M
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
162K+ 16.96% |
$160K - $311K
|
1.12M
$2.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
127K+ 295.32% |
$126K - $244K
|
170K
$397K
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
102KNew |
$101K - $196K
|
102K
$237K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
67.7K+ 147.25% |
$67K - $130K
|
114K
$265K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
54.1K+ 59.06% |
$53.6K - $104K
|
146K
$340K
|
|
|
Feb 11, 2025
Q4 2024
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
36.4KNew |
$36K - $69.9K
|
36.4K
$84.8K
|
|
|
Jan 22, 2025
Q4 2024
|
Pfg Investments, LLC
Woodbury, NY |
BUY
|
- |
20.7KNew |
$20.5K - $39.8K
|
20.7K
$48.3K
|
|
|
Feb 04, 2025
Q4 2024
|
Y Intercept (Hong Kong) LTD
|
BUY
|
- |
18.8KNew |
$18.6K - $36.1K
|
18.8K
$43.8K
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
18.5K+ 33.42% |
$18.3K - $35.6K
|
73.9K
$172K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
17.9K+ 6125.34% |
$17.7K - $34.3K
|
18.2K
$42.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
14.2K+ 3.79% |
$14K - $27.2K
|
388K
$904K
|
|
|
Feb 14, 2025
Q4 2024
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
BUY
|
- |
6.43K+ 13.67% |
$6.37K - $12.4K
|
53.5K
$125K
|
|
|
Feb 14, 2025
Q4 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
5.69K+ 24.07% |
$5.63K - $10.9K
|
29.3K
$68.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Lazard Asset Management LLC
New York, NY |
BUY
|
- |
1.26KNew |
$1.24K - $2.41K
|
1.26K
$2.92K
|
|
|
Feb 14, 2025
Q4 2024
|
Aptus Capital Advisors, LLC
|
BUY
|
- |
1.03K+ 4.59% |
$1.02K - $1.97K
|
23.4K
$54.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
656New |
$649 - $1.26K
|
656
$1.53K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
632New |
$626 - $1.21K
|
632
$1.47K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-531- 1.06% |
$526 - $1.02K
|
49.7K
$116K
|
|
|
Feb 10, 2025
Q4 2024
|
Kestra Advisory Services, LLC
|
SELL
|
- |
-2K- 12.5% |
$1.98K - $3.84K
|
14K
$32.6K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-2.39K- 1.3% |
$2.37K - $4.59K
|
181K
$423K
|
|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-9.11K- 21.0% |
$9.02K - $17.5K
|
34.3K
$79.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Point72 (Difc) LTD
Dubai, C0 |
SELL
|
- |
-10.7K- 92.23% |
$10.6K - $20.5K
|
901
$2.1K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-11.3K- 25.07% |
$11.2K - $21.7K
|
33.7K
$78.6K
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-11.6K- 31.76% |
$11.5K - $22.2K
|
24.9K
$57.9K
|
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-129K- 29.75% |
$128K - $249K
|
306K
$712K
|